Streptococcus pneumoniae sticks to dying lung cells, worsening secondary infection following flu Date: June 24, 2021 Source: University of Alabama at Birmingham Summary: Researchers have found a ...

CINCINNATI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational ...

Get ready to roll up your sleeve for another shot. The Centers for Disease Control and Prevention, already on guard against the flu, is expected to urge millions of Americans to get vaccinated ...

The agreement includes the commercialization and development rights to the newly approved EU drug Zavicefta (ceftazidime-avibactam), the ... for particular PBPs in MRSA in cSSTI and Streptococcus ...

Streptococcus pneumoniae from infecting the mice. The research suggests that vaccination of humans with live S. mitis might offer protection from some of the many serotypes of S. pneumoniae that ...

DUBLIN, Feb. 25, 2015 -- Actavis plc (NYSE: ACT) today announced the U.S. Food and Drug Administration (FDA) has approved AVYCAZ™ (ceftazidime-avibactam). AVYCAZ was approved for ...

pneumoniae and 28 patients with P. aeruginosa isolates. The 28-day all-cause mortality in patients with ceftazidime non-susceptible Gram-negative isolates was 8.2% in the Avycaz arm and 8.5% in the ...

But it did not investigate group A strep bacteria; rather, the study investigated Streptococcus pneumoniae and Staphylococcus aureus, which Mina said in an email, are “very different ...